Skip to content

Influenza Vaccination for Parents and Other Caregivers in the Pediatric Medical Home

Influenza Vaccination for Parents and Other Caregivers in the Pediatric Medical Home

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00812110
Enrollment
336
Registered
2008-12-19
Start date
2008-12-31
Completion date
2009-09-30
Last updated
2013-01-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Influenza

Keywords

Influenza prevention

Brief summary

We hypothesize that when offered influenza vaccine at little or no cost, in a setting where the value of the vaccine is connected to one's high risk child, vaccination rates for parents will approach 90-95%, similar to rates obtained in the Neonatal Intensive Care Unit environment.

Interventions

0.5 mL Deltoid Intramuscular Injection X 1

Sponsors

Akron Children's Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Parents or caregiver adults who accompany at-risk children to a Pediatric Care outpatient clinic appointment. High risk children are defined as those 0 to 5 years of age, or who have any of the following diagnoses: * Sickle cell disease * Asthma * Cystic fibrosis * Chronic renal disease * Congenital heart disease * Cancer * Any immunodeficiency

Exclusion criteria

* Caregivers of children residing in group homes * Persons whose children do not meet the Center for Disease Control (CDC) definition of high-risk * Persons who have had allergic reactions to influenza vaccination or any other vaccination in the past * Persons who are allergic to eggs or egg products * Persons who are allergic to thimerosol * Previous diagnosis of Guillain-Barré syndrome (GBS) * Persons who are moderately to severely ill at the time the vaccination is to be given

Design outcomes

Primary

MeasureTime frameDescription
Number of Participants Who Received Influenza Vaccine.1 hourCaregivers identified for participation were offered influenza vaccine. This describes the number who accepted vaccination

Secondary

MeasureTime frameDescription
Background Rate of Influenza Vaccination in the Parents/Caregivers of High Risk Pediatric Patients in a Low Income Population?16 monthsNumber of participants who received influenza vaccine the prior year.

Countries

United States

Participant flow

Recruitment details

During the 2008-2009 influenza season, 474 caregivers were approached. 292 agreed to participate,and had not received influenza vaccine.

Participants by arm

ArmCount
Caregivers
Caregivers of children at high risk, per CDC definitions, of complications of influenza.
292
Total292

Baseline characteristics

CharacteristicCaregivers
Age Continuous30.5 years
STANDARD_DEVIATION 10.6
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
0 Participants
Race (NIH/OMB)
Black or African American
171 Participants
Race (NIH/OMB)
More than one race
0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
21 Participants
Race (NIH/OMB)
White
100 Participants
Region of Enrollment
United States
292 participants
Sex: Female, Male
Female
235 Participants
Sex: Female, Male
Male
57 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
0 / 292
serious
Total, serious adverse events
0 / 292

Outcome results

Primary

Number of Participants Who Received Influenza Vaccine.

Caregivers identified for participation were offered influenza vaccine. This describes the number who accepted vaccination

Time frame: 1 hour

ArmMeasureValue (NUMBER)
CaregiversNumber of Participants Who Received Influenza Vaccine.250 participants
Secondary

Background Rate of Influenza Vaccination in the Parents/Caregivers of High Risk Pediatric Patients in a Low Income Population?

Number of participants who received influenza vaccine the prior year.

Time frame: 16 months

ArmMeasureValue (NUMBER)
CaregiversBackground Rate of Influenza Vaccination in the Parents/Caregivers of High Risk Pediatric Patients in a Low Income Population?69 participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026